Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30055154HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055155HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055156HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055157HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055158HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055159HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055160HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055161HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055162HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TVIS30055163HIVENSG00000100030.15protein_codingMAPK1YesNo5594P28482
Q1HBJ4
Q499G7
TCGA Plot Options
Drug Information
GeneMAPK1
DrugBank IDDB13930
Drug NameUlixertinib
Target IDBE0000923
UniProt IDP28482
Regulation Typeinhibitor
PubMed IDs28939558
CitationsGermann UA, Furey BF, Markland W, Hoover RR, Aronov AM, Roix JJ, Hale M, Boucher DM, Sorrell DA, Martinez-Botella G, Fitzgibbon M, Shapiro P, Wick MJ, Samadani R, Meshaw K, Groover A, DeCrescenzo G, Namchuk M, Emery CM, Saha S, Welsch DJ: Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib). Mol Cancer Ther. 2017 Nov;16(11):2351-2363. doi: 10.1158/1535-7163.MCT-17-0456. Epub 2017 Sep 22.
GroupsInvestigational
Direct Classification
SMILES[H]N([C@H](CO)C1=CC(Cl)=CC=C1)C(=O)C1=CC(=CN1[H])C1=CC(=NC=C1Cl)N([H])C(C)C
Pathways
PharmGKB
ChEMBLCHEMBL3590106